GLR Partners’s Johnson & Johnson JNJ Stock Holding History

GLR Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Sell	5,342 -33	-0.6%	-$7.69K	0.63%	42
2026 Q1	$1.31M	Buy	+5,375	New	+$1.25M	0.72%	39

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GLR Partners's JNJ Position: Q2 2026 in Review

GLR Partners reduced its Johnson & Johnson (JNJ) stake by 0.61% in Q2 2026, selling an estimated $7.69K and leaving 5,342 shares worth $1.36M. The position accounts for 0.63% of the portfolio, ranked #42.

GLR Partners first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,652 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

GLR Partners held 5,342 shares of Johnson & Johnson worth $1.36M as of Q2 2026.
GLR Partners sold 33 Johnson & Johnson shares in Q2 2026, an estimated $7.69K.
Johnson & Johnson made up 0.63% of GLR Partners's portfolio in Q2 2026, its #42 holding.
GLR Partners first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,652 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GLR Partners's 13F filing for Q2 2026, filed 27 Jul 2026.